The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...

Richard Bayliss is 44 years old and has sickle cell disease with hemoglobin SS disease. He’s in the final year of a master’s ...

Columnist Mary Shaniqua explains how to be an ally to the sickle cell community, and why that kind of support is essential ...

After moving from Sierra Leone to London, guest columnist Richard Bayliss received a proper diagnosis and care plan for his sickle cell.

The researchers found that people who were economically deprived, even in the absence of sickle cell disease, had more ...

Columnist Oluwatosin Adesoye had faced many sickle cell complications, but her hypothyroidism diagnosis was, at first, ...

As last year drew to a close, a thought-provoking post in the Sickle Cell Celebs Facebook group inspired me to reflect on what I wish people understood about sickle cell disease. This introspection ...